Summary & Overview
HCPCS J3471: Hyaluronidase, Ovine, Preservative-Free Injection
HCPCS Level II code J3471 denotes injectable hyaluronidase (ovine), preservative-free, billed per 1 USP unit (up to 999 units). This medication is used as an adjunct to facilitate the dispersion and absorption of co-administered injectable therapies, and it carries importance for billing clarity in outpatient, office, and infusion settings nationwide. Accurate coding of J3471 affects drug utilization records, reimbursement workflows, and clinical documentation tied to enzyme adjunct therapy.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the code’s clinical context, typical sites of service, and the common modifiers associated with drug administration claims. The publication summarizes benchmark considerations, payer coverage patterns where available, and compliance considerations relevant to billing injectable biologic adjuncts. It also outlines what documentation and coding elements are typically relevant for claims processing and audit readiness. Data not available in the input is identified explicitly where applicable.
Billing Code Overview
HCPCS Level II code J3471 describes an injectable hyaluronidase, ovine, preservative free, billed per 1 USP unit (up to 999 USP units). This drug is typically used as an adjuvant to improve the dispersion and absorption of other injected drugs, and is administered via injection.
-
Service type: Injectable medication administration (enzyme adjunct)
-
Typical site of service: Ambulatory infusion clinic, physician office, or hospital outpatient setting
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related procedure codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing ophthalmic or subcutaneous procedures where dispersion of injected medication is difficult due to tissue barriers or prior surgical scarring. For example, a 68-year-old patient presenting to an ophthalmology clinic for periocular injection of a corticosteroid for posterior orbital inflammation, or a patient in a surgical clinic requiring infiltration of local anesthetic around dense subcutaneous adhesions prior to a minor skin procedure. The clinical workflow includes consent and medication reconciliation, preparation of preservative-free ovine hyaluronidase reconstituted to the ordered units, verification of the per-unit dosing (J3471 billed per 1 USP unit), administration by the ophthalmologist or surgeon to increase tissue permeability and facilitate spread of concurrently injected agents, post-injection observation for allergic reaction, and documentation of units administered, injection site, lot numbers, and patient response in the medical record. Typical sites of service are outpatient surgical centers, hospital outpatient departments, ophthalmology clinics, and office-based procedure suites.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug or biological product discarded | When a portion of a single-use vial of hyaluronidase is discarded and cannot be billed or repurposed. |